Bain Capital Public Equity Management II’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Bain Capital Public Equity Management II's BMY Position: Q2 2021 in Review
Bain Capital Public Equity Management II sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 531,424 shares — an estimated $33.5M sold.
Bain Capital Public Equity Management II first reported a position in BMY in Q1 2021 and held it in 1 quarter. The position peaked at $33.5M in Q1 2021. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.
- Bain Capital Public Equity Management II reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
- Bain Capital Public Equity Management II sold 531,424 Bristol-Myers Squibb shares in Q2 2021, an estimated $33.5M.
- Bain Capital Public Equity Management II first reported a position in Bristol-Myers Squibb in Q1 2021 and held it in 1 quarter.
- Bain Capital Public Equity Management II's Bristol-Myers Squibb position peaked at $33.5M in Q1 2021.
- 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.
Based on Bain Capital Public Equity Management II's 13F filing for Q2 2021, filed 16 Aug 2021.